Saibishkumar Elantholi P, MacKenzie Marc A, Severin Diane, Mihai Alina, Hanson John, Daly Helene, Fallone Gino, Parliament Matthew B, Abdulkarim Bassam S
Division of Radiation Oncology, Cross Cancer Institute, University of Alberta, Edmonton, AB, Canada.
Int J Radiat Oncol Biol Phys. 2008 Feb 1;70(2):485-91. doi: 10.1016/j.ijrobp.2007.06.049. Epub 2007 Sep 19.
To evaluate the feasibility of skin-sparing by configuring it as an organ-at-risk (OAR) while delivering whole-breast intensity-modulated radiotherapy (IMRT) in early breast cancer.
Archival computed tomography scan images of 14 left-sided early-breast tumor patients who had undergone lumpectomy were selected for this study. Skin was contoured as a 4- to 5-mm strip extending from the patient outline to anterior margin of the breast planning target volume (PTV). Two IMRT plans were generated by the helical tomotherapy approach to deliver 50 Gy in 25 fractions to the breast alone: one with skin dose constraints (skin-sparing plan) and the other without (non-skin-sparing plan). Comparison of the plans was done using a two-sided paired Student t test.
The mean skin dose and volume of skin receiving 50 Gy were significantly less with the skin-sparing plan compared with non-skin-sparing plan (42.3 Gy vs. 47.7 Gy and 12.2% vs. 57.8% respectively; p < 0.001). The reduction in skin dose was confirmed by TLD measurements in anthropomorphic phantom using the same plans. Dose-volume analyses for other OARs were similar in both plans.
By configuring the skin as an OAR, it is possible to achieve skin dose reduction while delivering whole-breast IMRT without compromising dose profiles to PTV and OARs.
评估在早期乳腺癌全乳调强放疗(IMRT)过程中,将皮肤设定为危及器官(OAR)以实现保留皮肤的可行性。
本研究选取了14例接受保乳手术的左侧早期乳腺癌患者的存档计算机断层扫描图像。将皮肤勾勒为一条从患者轮廓延伸至乳房计划靶体积(PTV)前缘的4至5毫米宽的条带。通过螺旋断层放疗方法生成两个IMRT计划,仅对乳房给予25次分割共50 Gy的剂量:一个有皮肤剂量限制(保留皮肤计划),另一个没有(不保留皮肤计划)。使用双侧配对学生t检验对计划进行比较。
与不保留皮肤计划相比,保留皮肤计划的平均皮肤剂量和接受50 Gy照射的皮肤体积显著更低(分别为42.3 Gy对47.7 Gy和12.2%对57.8%;p < 0.001)。使用相同计划在人体模型中进行热释光剂量测量证实了皮肤剂量的降低。两个计划中其他危及器官的剂量体积分析相似。
通过将皮肤设定为危及器官,在进行全乳IMRT时可以降低皮肤剂量,同时不影响向PTV和危及器官的剂量分布。